Structure

Physi-Chem Properties

Molecular Weight:  524.2
Volume:  534.582
LogP:  4.266
LogD:  3.696
LogS:  -5.763
# Rotatable Bonds:  6
TPSA:  90.91
# H-Bond Aceptor:  9
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.402
Synthetic Accessibility Score:  4.317
Fsp3:  0.414
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.891
MDCK Permeability:  2.7813877750304528e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.082
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.319

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.012
Plasma Protein Binding (PPB):  99.95368194580078%
Volume Distribution (VD):  1.13
Pgp-substrate:  2.0999691486358643%

ADMET: Metabolism

CYP1A2-inhibitor:  0.075
CYP1A2-substrate:  0.977
CYP2C19-inhibitor:  0.821
CYP2C19-substrate:  0.959
CYP2C9-inhibitor:  0.837
CYP2C9-substrate:  0.675
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.893
CYP3A4-inhibitor:  0.961
CYP3A4-substrate:  0.927

ADMET: Excretion

Clearance (CL):  10.071
Half-life (T1/2):  0.243

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  0.626
Drug-inuced Liver Injury (DILI):  0.965
AMES Toxicity:  0.129
Rat Oral Acute Toxicity:  0.681
Maximum Recommended Daily Dose:  0.878
Skin Sensitization:  0.31
Carcinogencity:  0.535
Eye Corrosion:  0.252
Eye Irritation:  0.796
Respiratory Toxicity:  0.322

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC261714

Natural Product ID:  NPC261714
Common Name*:   Antrodioxolanone
IUPAC Name:   (4S,5R)-4,5-dimethyl-4,5-bis[2-(3,4,6-trimethoxy-2-methylphenyl)ethynyl]-1,3-dioxolan-2-one
Synonyms:   antrodioxolanone
Standard InCHIKey:  NJECTZSLZHQUFD-ISILISOKSA-N
Standard InCHI:  InChI=1S/C29H32O9/c1-17-19(21(31-5)15-23(33-7)25(17)35-9)11-13-28(3)29(4,38-27(30)37-28)14-12-20-18(2)26(36-10)24(34-8)16-22(20)32-6/h15-16H,1-10H3/t28-,29+
SMILES:  COc1cc(OC)c(c(c1C#C[C@]1(C)OC(=O)O[C@]1(C)C#Cc1c(OC)cc(c(c1C)OC)OC)C)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL229460
PubChem CID:   16737472
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002341] Phenol ethers
        • [CHEMONTID:0000138] Anisoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[14738384]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota fruiting bodies n.a. n.a. PMID[16643055]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[17559265]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[24387703]
NPO30573 Antrodia camphorata Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. Database[HerDing]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 100000.0 nM PMID[534835]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC261714 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8864 High Similarity NPC52593
0.8788 High Similarity NPC64391
0.8759 High Similarity NPC185680
0.8759 High Similarity NPC145722
0.8759 High Similarity NPC256776
0.8741 High Similarity NPC258483
0.8732 High Similarity NPC326144
0.8702 High Similarity NPC264885
0.8671 High Similarity NPC318286
0.8671 High Similarity NPC327651
0.8662 High Similarity NPC218510
0.8662 High Similarity NPC76415
0.8643 High Similarity NPC201404
0.8643 High Similarity NPC290714
0.8643 High Similarity NPC53722
0.8633 High Similarity NPC197166
0.8633 High Similarity NPC32189
0.8633 High Similarity NPC143895
0.8611 High Similarity NPC321958
0.8611 High Similarity NPC321696
0.8603 High Similarity NPC470624
0.8603 High Similarity NPC237169
0.8571 High Similarity NPC196420
0.8571 High Similarity NPC191768
0.8571 High Similarity NPC283170
0.8571 High Similarity NPC92869
0.8561 High Similarity NPC211231
0.8551 High Similarity NPC1474
0.8519 High Similarity NPC202904
0.8519 High Similarity NPC189248
0.8511 High Similarity NPC9068
0.8511 High Similarity NPC30951
0.8511 High Similarity NPC6369
0.85 High Similarity NPC11453
0.8493 Intermediate Similarity NPC327352
0.8493 Intermediate Similarity NPC252281
0.8493 Intermediate Similarity NPC477375
0.8493 Intermediate Similarity NPC198129
0.8462 Intermediate Similarity NPC174522
0.8456 Intermediate Similarity NPC149008
0.8456 Intermediate Similarity NPC283114
0.8456 Intermediate Similarity NPC207702
0.8451 Intermediate Similarity NPC216434
0.8451 Intermediate Similarity NPC103448
0.8451 Intermediate Similarity NPC284464
0.8446 Intermediate Similarity NPC224472
0.844 Intermediate Similarity NPC865
0.8435 Intermediate Similarity NPC322426
0.8435 Intermediate Similarity NPC477374
0.8435 Intermediate Similarity NPC477376
0.8403 Intermediate Similarity NPC324962
0.8378 Intermediate Similarity NPC316989
0.8369 Intermediate Similarity NPC121651
0.8367 Intermediate Similarity NPC316676
0.8367 Intermediate Similarity NPC325720
0.8357 Intermediate Similarity NPC474600
0.8356 Intermediate Similarity NPC87295
0.8356 Intermediate Similarity NPC33832
0.8345 Intermediate Similarity NPC65183
0.8345 Intermediate Similarity NPC261812
0.8345 Intermediate Similarity NPC72046
0.8345 Intermediate Similarity NPC475856
0.8345 Intermediate Similarity NPC102256
0.8333 Intermediate Similarity NPC308739
0.8333 Intermediate Similarity NPC16791
0.8333 Intermediate Similarity NPC217708
0.8333 Intermediate Similarity NPC184641
0.8333 Intermediate Similarity NPC36531
0.8333 Intermediate Similarity NPC53669
0.8333 Intermediate Similarity NPC77237
0.8333 Intermediate Similarity NPC472562
0.8333 Intermediate Similarity NPC80326
0.8333 Intermediate Similarity NPC230538
0.8333 Intermediate Similarity NPC474295
0.8333 Intermediate Similarity NPC297271
0.8333 Intermediate Similarity NPC126405
0.8333 Intermediate Similarity NPC229172
0.8333 Intermediate Similarity NPC133934
0.8333 Intermediate Similarity NPC103637
0.8333 Intermediate Similarity NPC474514
0.8333 Intermediate Similarity NPC184684
0.8311 Intermediate Similarity NPC85141
0.8309 Intermediate Similarity NPC186845
0.8309 Intermediate Similarity NPC88297
0.8309 Intermediate Similarity NPC9891
0.8299 Intermediate Similarity NPC116019
0.8298 Intermediate Similarity NPC150534
0.8298 Intermediate Similarity NPC148893
0.8298 Intermediate Similarity NPC73071
0.8298 Intermediate Similarity NPC49235
0.8298 Intermediate Similarity NPC25333
0.8298 Intermediate Similarity NPC236522
0.8288 Intermediate Similarity NPC475868
0.8286 Intermediate Similarity NPC266848
0.8286 Intermediate Similarity NPC196937
0.8286 Intermediate Similarity NPC471391
0.8286 Intermediate Similarity NPC471390
0.8286 Intermediate Similarity NPC136750
0.8276 Intermediate Similarity NPC474808
0.8273 Intermediate Similarity NPC192255
0.8273 Intermediate Similarity NPC184928
0.8273 Intermediate Similarity NPC141493
0.8267 Intermediate Similarity NPC477378
0.8267 Intermediate Similarity NPC471154
0.8267 Intermediate Similarity NPC475229
0.8264 Intermediate Similarity NPC312199
0.8264 Intermediate Similarity NPC58137
0.8264 Intermediate Similarity NPC300798
0.8258 Intermediate Similarity NPC308217
0.8255 Intermediate Similarity NPC473989
0.8255 Intermediate Similarity NPC24425
0.8252 Intermediate Similarity NPC113550
0.8248 Intermediate Similarity NPC471986
0.8243 Intermediate Similarity NPC304821
0.8227 Intermediate Similarity NPC474478
0.8227 Intermediate Similarity NPC31530
0.8219 Intermediate Similarity NPC121661
0.8219 Intermediate Similarity NPC239254
0.8219 Intermediate Similarity NPC73467
0.8219 Intermediate Similarity NPC172171
0.8214 Intermediate Similarity NPC7744
0.8212 Intermediate Similarity NPC24562
0.8212 Intermediate Similarity NPC474606
0.8212 Intermediate Similarity NPC477377
0.8209 Intermediate Similarity NPC477886
0.8207 Intermediate Similarity NPC287124
0.8207 Intermediate Similarity NPC191231
0.8201 Intermediate Similarity NPC224157
0.8201 Intermediate Similarity NPC63574
0.8201 Intermediate Similarity NPC79184
0.8201 Intermediate Similarity NPC307042
0.8201 Intermediate Similarity NPC476399
0.8201 Intermediate Similarity NPC192687
0.8201 Intermediate Similarity NPC184814
0.82 Intermediate Similarity NPC475756
0.82 Intermediate Similarity NPC303519
0.8188 Intermediate Similarity NPC328682
0.8188 Intermediate Similarity NPC281864
0.8188 Intermediate Similarity NPC474623
0.8188 Intermediate Similarity NPC54321
0.8188 Intermediate Similarity NPC474651
0.8182 Intermediate Similarity NPC283949
0.8182 Intermediate Similarity NPC474612
0.8175 Intermediate Similarity NPC112571
0.8175 Intermediate Similarity NPC50683
0.8175 Intermediate Similarity NPC285725
0.817 Intermediate Similarity NPC29727
0.8169 Intermediate Similarity NPC240915
0.8169 Intermediate Similarity NPC189474
0.8169 Intermediate Similarity NPC474139
0.8163 Intermediate Similarity NPC110763
0.8163 Intermediate Similarity NPC197352
0.8163 Intermediate Similarity NPC205316
0.8163 Intermediate Similarity NPC189239
0.8163 Intermediate Similarity NPC307466
0.8163 Intermediate Similarity NPC166506
0.8158 Intermediate Similarity NPC473425
0.8158 Intermediate Similarity NPC198461
0.8156 Intermediate Similarity NPC58585
0.8151 Intermediate Similarity NPC474288
0.8146 Intermediate Similarity NPC104353
0.8133 Intermediate Similarity NPC149505
0.8129 Intermediate Similarity NPC10225
0.8129 Intermediate Similarity NPC190144
0.8129 Intermediate Similarity NPC58164
0.812 Intermediate Similarity NPC254625
0.812 Intermediate Similarity NPC119949
0.812 Intermediate Similarity NPC475961
0.8117 Intermediate Similarity NPC475592
0.8116 Intermediate Similarity NPC474670
0.8116 Intermediate Similarity NPC473093
0.8116 Intermediate Similarity NPC473092
0.8116 Intermediate Similarity NPC8050
0.8112 Intermediate Similarity NPC471182
0.8112 Intermediate Similarity NPC286843
0.8112 Intermediate Similarity NPC205442
0.8108 Intermediate Similarity NPC162193
0.8108 Intermediate Similarity NPC154971
0.8108 Intermediate Similarity NPC252286
0.8106 Intermediate Similarity NPC304208
0.8106 Intermediate Similarity NPC52464
0.8105 Intermediate Similarity NPC476065
0.8105 Intermediate Similarity NPC238834
0.8095 Intermediate Similarity NPC477701
0.8095 Intermediate Similarity NPC141569
0.8095 Intermediate Similarity NPC143092
0.8095 Intermediate Similarity NPC166884
0.8085 Intermediate Similarity NPC319969
0.8085 Intermediate Similarity NPC6451
0.8082 Intermediate Similarity NPC40237
0.8082 Intermediate Similarity NPC41782
0.8082 Intermediate Similarity NPC151423
0.8079 Intermediate Similarity NPC210642
0.8079 Intermediate Similarity NPC13985
0.8071 Intermediate Similarity NPC126836
0.8071 Intermediate Similarity NPC299221
0.8071 Intermediate Similarity NPC51840
0.8071 Intermediate Similarity NPC474617
0.8071 Intermediate Similarity NPC234488
0.8071 Intermediate Similarity NPC311680

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC261714 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8209 Intermediate Similarity NPD3705 Approved
0.7974 Intermediate Similarity NPD37 Approved
0.7857 Intermediate Similarity NPD3018 Phase 2
0.7821 Intermediate Similarity NPD4966 Approved
0.7821 Intermediate Similarity NPD4967 Phase 2
0.7821 Intermediate Similarity NPD4965 Approved
0.7754 Intermediate Similarity NPD2981 Phase 2
0.7722 Intermediate Similarity NPD6234 Discontinued
0.7698 Intermediate Similarity NPD2983 Phase 2
0.7698 Intermediate Similarity NPD2982 Phase 2
0.7697 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD7199 Phase 2
0.7622 Intermediate Similarity NPD3027 Phase 3
0.7537 Intermediate Similarity NPD5283 Phase 1
0.7531 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7228 Approved
0.7372 Intermediate Similarity NPD1653 Approved
0.7361 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD3539 Phase 1
0.7321 Intermediate Similarity NPD7240 Approved
0.731 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD3540 Phase 1
0.723 Intermediate Similarity NPD1613 Approved
0.723 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD6674 Discontinued
0.7152 Intermediate Similarity NPD6232 Discontinued
0.7134 Intermediate Similarity NPD5494 Approved
0.7126 Intermediate Similarity NPD7473 Discontinued
0.7115 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD3817 Phase 2
0.7097 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD5536 Phase 2
0.7051 Intermediate Similarity NPD7124 Phase 2
0.7041 Intermediate Similarity NPD5844 Phase 1
0.7037 Intermediate Similarity NPD2801 Approved
0.7034 Intermediate Similarity NPD6696 Suspended
0.7027 Intermediate Similarity NPD4625 Phase 3
0.6987 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6982 Remote Similarity NPD3818 Discontinued
0.6974 Remote Similarity NPD6111 Discontinued
0.6972 Remote Similarity NPD1357 Approved
0.6959 Remote Similarity NPD4908 Phase 1
0.6957 Remote Similarity NPD7028 Phase 2
0.6954 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6948 Remote Similarity NPD7266 Discontinued
0.6944 Remote Similarity NPD1611 Approved
0.6941 Remote Similarity NPD7054 Approved
0.6939 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1465 Phase 2
0.6918 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6909 Remote Similarity NPD4055 Discovery
0.6901 Remote Similarity NPD7074 Phase 3
0.6901 Remote Similarity NPD7472 Approved
0.6897 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6894 Remote Similarity NPD4005 Discontinued
0.6892 Remote Similarity NPD2861 Phase 2
0.689 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6887 Remote Similarity NPD4060 Phase 1
0.6879 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6867 Remote Similarity NPD5109 Approved
0.6867 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6867 Remote Similarity NPD5110 Phase 2
0.6867 Remote Similarity NPD5111 Phase 2
0.6853 Remote Similarity NPD5691 Approved
0.6849 Remote Similarity NPD4749 Approved
0.6848 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6848 Remote Similarity NPD3882 Suspended
0.6845 Remote Similarity NPD3787 Discontinued
0.6839 Remote Similarity NPD1375 Discontinued
0.6829 Remote Similarity NPD7819 Suspended
0.6828 Remote Similarity NPD1610 Phase 2
0.6818 Remote Similarity NPD3748 Approved
0.681 Remote Similarity NPD5090 Approved
0.681 Remote Similarity NPD5089 Approved
0.6809 Remote Similarity NPD709 Approved
0.6806 Remote Similarity NPD4626 Approved
0.6805 Remote Similarity NPD3926 Phase 2
0.6795 Remote Similarity NPD970 Clinical (unspecified phase)
0.6792 Remote Similarity NPD4357 Discontinued
0.6783 Remote Similarity NPD1548 Phase 1
0.6782 Remote Similarity NPD7549 Discontinued
0.6782 Remote Similarity NPD7808 Phase 3
0.6768 Remote Similarity NPD3384 Approved
0.6768 Remote Similarity NPD3383 Approved
0.6768 Remote Similarity NPD1934 Approved
0.6768 Remote Similarity NPD3382 Approved
0.6763 Remote Similarity NPD228 Approved
0.6755 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6746 Remote Similarity NPD7229 Phase 3
0.6735 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6735 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6732 Remote Similarity NPD3657 Discovery
0.6732 Remote Similarity NPD1933 Approved
0.6731 Remote Similarity NPD5763 Approved
0.6731 Remote Similarity NPD5762 Approved
0.6727 Remote Similarity NPD4585 Approved
0.6724 Remote Similarity NPD7251 Discontinued
0.6721 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6713 Remote Similarity NPD7644 Approved
0.6712 Remote Similarity NPD1091 Approved
0.6712 Remote Similarity NPD422 Phase 1
0.6711 Remote Similarity NPD4624 Approved
0.6709 Remote Similarity NPD7466 Approved
0.669 Remote Similarity NPD6671 Approved
0.6689 Remote Similarity NPD7095 Approved
0.6689 Remote Similarity NPD2922 Phase 1
0.6687 Remote Similarity NPD5297 Approved
0.6686 Remote Similarity NPD1247 Approved
0.6685 Remote Similarity NPD6843 Phase 3
0.6685 Remote Similarity NPD6842 Approved
0.6685 Remote Similarity NPD6841 Approved
0.6667 Remote Similarity NPD6099 Approved
0.6667 Remote Similarity NPD2935 Discontinued
0.6667 Remote Similarity NPD2438 Suspended
0.6667 Remote Similarity NPD919 Approved
0.6667 Remote Similarity NPD6797 Phase 2
0.6667 Remote Similarity NPD3620 Phase 2
0.6667 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2219 Phase 1
0.6667 Remote Similarity NPD6100 Approved
0.6648 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6646 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6646 Remote Similarity NPD2534 Approved
0.6646 Remote Similarity NPD2532 Approved
0.6646 Remote Similarity NPD2533 Approved
0.6644 Remote Similarity NPD3496 Discontinued
0.6629 Remote Similarity NPD6559 Discontinued
0.6627 Remote Similarity NPD5677 Discontinued
0.6627 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6625 Remote Similarity NPD5058 Phase 3
0.6623 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6623 Remote Similarity NPD6355 Discontinued
0.6621 Remote Similarity NPD1651 Approved
0.6608 Remote Similarity NPD5242 Approved
0.6604 Remote Similarity NPD3750 Approved
0.6604 Remote Similarity NPD3892 Phase 2
0.6604 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6599 Remote Similarity NPD1281 Approved
0.6596 Remote Similarity NPD5535 Approved
0.659 Remote Similarity NPD8252 Approved
0.659 Remote Similarity NPD8099 Discontinued
0.659 Remote Similarity NPD8251 Approved
0.659 Remote Similarity NPD3751 Discontinued
0.6587 Remote Similarity NPD5402 Approved
0.6587 Remote Similarity NPD5353 Approved
0.6585 Remote Similarity NPD7261 Clinical (unspecified phase)
0.6584 Remote Similarity NPD1511 Approved
0.6584 Remote Similarity NPD6799 Approved
0.6579 Remote Similarity NPD2669 Clinical (unspecified phase)
0.6578 Remote Similarity NPD7680 Approved
0.6573 Remote Similarity NPD7157 Approved
0.6573 Remote Similarity NPD6387 Discontinued
0.657 Remote Similarity NPD6166 Phase 2
0.657 Remote Similarity NPD6167 Clinical (unspecified phase)
0.657 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6558 Remote Similarity NPD2979 Phase 3
0.6552 Remote Similarity NPD8156 Discontinued
0.6545 Remote Similarity NPD4675 Approved
0.6545 Remote Similarity NPD4678 Approved
0.6541 Remote Similarity NPD4237 Approved
0.6541 Remote Similarity NPD4236 Phase 3
0.6541 Remote Similarity NPD1652 Phase 2
0.6538 Remote Similarity NPD6896 Approved
0.6538 Remote Similarity NPD7097 Phase 1
0.6538 Remote Similarity NPD6895 Approved
0.6536 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6536 Remote Similarity NPD5718 Phase 2
0.6536 Remote Similarity NPD7985 Registered
0.6534 Remote Similarity NPD7685 Pre-registration
0.6527 Remote Similarity NPD8455 Phase 2
0.6527 Remote Similarity NPD2977 Approved
0.6527 Remote Similarity NPD2978 Approved
0.6524 Remote Similarity NPD5005 Approved
0.6524 Remote Similarity NPD5006 Approved
0.6524 Remote Similarity NPD4210 Discontinued
0.6513 Remote Similarity NPD1008 Clinical (unspecified phase)
0.651 Remote Similarity NPD5327 Phase 3
0.6509 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6507 Remote Similarity NPD5585 Approved
0.6506 Remote Similarity NPD6386 Approved
0.6506 Remote Similarity NPD6385 Approved
0.6503 Remote Similarity NPD1512 Approved
0.6503 Remote Similarity NPD3647 Clinical (unspecified phase)
0.65 Remote Similarity NPD6658 Clinical (unspecified phase)
0.65 Remote Similarity NPD4109 Clinical (unspecified phase)
0.65 Remote Similarity NPD4110 Phase 3
0.6497 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6497 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6497 Remote Similarity NPD4108 Discontinued
0.6494 Remote Similarity NPD554 Clinical (unspecified phase)
0.6494 Remote Similarity NPD6233 Phase 2
0.6491 Remote Similarity NPD8127 Discontinued
0.6484 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6479 Remote Similarity NPD7843 Approved
0.6478 Remote Similarity NPD4664 Clinical (unspecified phase)
0.6475 Remote Similarity NPD1358 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data